ArticleFrontiers in oncology2018
Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas.
Article in Frontiers in oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 5 syntheses or guidelines pooled it, 57 citations in OpenAlex.
- Efficacy and safety of oral propranolol and topical timolol in the treatment of infantile hemangioma: a meta-analysis and systematic review.Frontiers in pharmacology · 2024Pooled it
- The Efficacy and Safety of Topical β-Blockers in Treating Infantile Hemangiomas: A Meta-Analysis Including 11 Randomized Controlled Trials.Dermatology (Basel, Switzerland) · 2021Pooled it
- The effectiveness and safety of topical β-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies.British journal of clinical pharmacology · 2020Pooled it
- Efficacy of Combined Topical Timolol and Oral Propranolol for Treating Infantile Hemangioma: A Meta-Analysis of Randomized Controlled Trials.Frontiers in pharmacology · 2020Pooled it
- Efficacy and adverse effects of oral propranolol in infantile hemangioma: a meta-analysis of comparative studies.World journal of pediatrics : WJP · 2019Pooled it
- Nanotechnology in Infantile Hemangioma Management.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2025Article
- Non-coding RNA in infantile hemangioma.Pediatric research · 2024Review
- Efficiency of Topical Beta-Blockers for Epistaxis Control in Ulcerated Infantile Hemangioma.Cureus · 2024Article
- MicroRNA‑203a‑3p improves bleomycin and pingyangmycin sensitivity by inactivating the PI3K/AKT pathway in hemangioma.Experimental and therapeutic medicine · 2024Article
- Pediatric Vascular Anomalies: A Clinical and Radiological Perspective.The Indian journal of radiology & imaging · 2024Review
- Efficacy of 0.5% timolol maleate gel in the management of infantile hemangiomas.Pakistan journal of medical sciences · 2024Article
- Good Clinical Responders to Topical Timolol in Patients with Infantile Hemangiomas: A 7-Year Retrospective Study of 328 Korean Patients.Annals of dermatology · 2022Article
- Update on Treatment of Infantile Hemangiomas: What's New in the Last Five Years?Frontiers in pharmacology · 2022Review
- Infantile Hemangiomas: An Update on Pathogenesis and Treatment.Journal of clinical medicine · 2021Review
- Topical beta-blockers in dermatologic therapy.Dermatologic therapy · 2021Review
- Efficacy Evaluation of 755-nm Long-Pulse Alexandrite Laser Combined with 0.5% Timolol Maleate Eye Drops in the Treatment of Thicker Infantile Hemangioma.Clinical, cosmetic and investigational dermatology · 2021Article
- Treatment patterns and outcomes in children with infantile hemangiomas: A retrospective observational analysis.SAGE open medicine · 2021Article
- Using Esterase Selectivity to Determine theACS pharmacology & translational science · 2020Article
- Infantile Hemangioma: A Review of Current Pharmacotherapy Treatment and Practice Pearls.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2020Review
- Failed Treatment of Classic Kaposi's Sarcoma with Topical Timolol: Case Report and Review of the Literature.Cureus · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.